Pnc Financial Services Group, Inc. Entera Bio Ltd. Transaction History

Pnc Financial Services Group, Inc.

  • $156 Billion
  • Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Entera Bio Ltd. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 13,000 shares of ENTX stock, worth $27,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,000
Previous 13,000 -0.0%
Holding current value
$27,950
Previous $23,000 4.35%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.6 - $0.88 $1,800 - $2,640
3,000 Added 30.0%
13,000 $9,000
Q1 2022

May 12, 2022
BUY
$1.91 - $3.23 $19,100 - $32,300
10,000 New
10,000 $28,000

Others Institutions Holding ENTX

# of Institutions
21
Shares Held
5.34M
Call Options Held
2.6K
Put Options Held
100
View Full List

About Entera Bio Ltd.

ENTX Quotes by TradingView
  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $61.9M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email